Mackenzie Financial’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,770
Closed -$414K 1572
2023
Q1
$414K Buy
+1,770
New +$447K ﹤0.01% 1075
2022
Q3
Sell
-1,859
Closed -$340K 1482
2022
Q2
$340K Buy
1,859
+361
+24% +$72K ﹤0.01% 1048
2022
Q1
$385K Sell
1,498
-85
-5% -$19.4K ﹤0.01% 1043
2021
Q4
$364K Sell
1,583
-258
-14% -$63K ﹤0.01% 1076
2021
Q3
$429K Buy
1,841
+627
+52% +$131K ﹤0.01% 1019
2021
Q2
$235K Buy
+1,214
New +$241K ﹤0.01% 1125

Other funds holding INSP

Mackenzie Financial's INSP Position: Q2 2023 in Review

Mackenzie Financial sold out of Inspire Medical Systems (INSP) in Q2 2023, closing a stake of 1,770 shares — an estimated $414K sold.

Mackenzie Financial first reported a position in INSP in Q2 2021 and held it in 6 quarters. The position peaked at $429K in Q3 2021. 407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

  • Mackenzie Financial reported no remaining Inspire Medical Systems position as of Q2 2023 after selling out during the quarter.
  • Mackenzie Financial sold 1,770 Inspire Medical Systems shares in Q2 2023, an estimated $414K.
  • Mackenzie Financial first reported a position in Inspire Medical Systems in Q2 2021 and held it in 6 quarters.
  • Mackenzie Financial's Inspire Medical Systems position peaked at $429K in Q3 2021.
  • 407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on Mackenzie Financial's 13F filing for Q2 2023, filed 3 Aug 2023.